Expression of 5α-reductase type 1 in breast cancer and adjacent non-malignant tissue: An immunohistochemical study

Hormone Molecular Biology and Clinical Investigation

Volumn 3, Issue 2, 2010, Pages 411-415

  Zhao, Gang ^a,b   Lu, Liu ^a,b   Luu The, Van ^a   Fernand, Labrie ^a   Fan, Zhimin ^a,b   Pelletier, Georges ^a  

^a LAVAL UNIVERSITY   (Canada)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

5 reductase type 1; androgens; breast cancer; immunohistochemistry; mammary gland

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROGESTERONE RECEPTOR; STEROID 5ALPHA REDUCTASE 1;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CELL DIVISION; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; LYMPH NODE; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 84905053976     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/HMBCI.2010.046     Document Type: Article

References (26)

1. Pasqualini JR. The selective estrogen enzyme modulators in breast cancer: a review. Biochem Biophys Acta 2004;1654: 123-4.
2. Miyoshi Y., Ando A., Shiba E., Taguchi T., Tamaki Y., Noguchi S. Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers. Int J Cancer 2001;94:685-9.
3. Chetrite GS., Cortes-Prieto J., Philippe JC., Wright F., Pasqualini JR. Comparison of estrogen concentrations., estrone sulfatase and aromatase activities in normal., and in cancerous., human breast tissues. J Steroid Biochem Mol Biol 2000;72:23-7.
4. Song D., Liu G., Luu-The V., Zhao D., Wang L., Zhang H., Xueling G., Li S., Desy L., Labrie F., Pelletier G. Expression of aromatase and 17beta-hydoxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study. J Steroid Biochem Mol Biol 2006;101:136-44.
5. Suzuki T., Miki Y., Moriya T., Akahira J., Ishida T., Hirakawa H., Yamaguchi Y., Hayashi S., Sasano H. 5a-Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer 2007;20:285-91.
6. Birrell SN., Hall RE., Tilley WD. Role of the androgen receptor in human breast cancer. J Mammary Gland Biol Neoplasia 1998;3:95-103.
7. Labrie F., Luu-The V., Labrie C., Belanger A., Simard J., Lin XS., Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003; 24:152-82.
8. Dimitrakakis C., Zhou J., Wang J., Belanger A., Labrie F., Cheng C., Powell D., Bondy C. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 2003;10:292-8.
9. Han B., Li S., Song D., Poisson-Pare D., Liu G., Luu-The V., Ouel-let J., Li S., Labrie F., Pelletier G. Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to cli-nicopathological parameters. J Steroid Biochem Mol Biol 2008;112:194-200.
10. Recchione C., Venturelli E., Manzari A., Cavalleri A., Martinetti A., Secreto G. Testosterone., dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues. J Sterioid Biochem Mol Biol 1995;52:541-6.
11. Suzuki T., Miki Y., Nakamura T., Moriya T., Ito K., Ohuchi N., Sasano H. Sex steroid-producing enzymes in human breast cancer. Endocr Relat Cancer 2005;12:701-20.
12. Labrie F. Dehydroepiandrosterone., androgens and the mammary gland. Gyn Endocrinol 2006;22:118-30.
13. Russell DW., Wilson JD. Steroid 5-alpha-reductase: two genes/ two enzymes. Annu Rev Biochem 1994;63:25-61.
14. Jin Y., Penning TM. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Pract Res Clin Endocrinol Metab 2001; 15:79-94.
15. Suzuki T., Darnel AD., Akahira JI., Ariga N., Ogawa S., Kaneko C., Takeyama J., Moriya T., Sasano H. 5alpha-reductase in human breast carcinoma: possible modulator of in situ androgenic actions. J Clin Endocr Metab 2001;86:2250-7.
16. Segaloff A., Gordon D., Horwitt BN., Schlosser JV., Murison PJ. Hormonal therapy in cancer of the breast. 1. The effect of testosterone propionate therapy on clinical course and hormonal excretion. Cancer 1951;4:319-23.
17. Fels E. Treatment of breast cancer with testosterone propionate-a preliminary report. J Clin Endocrinol 1944;4:121-5.
18. Kennedy BJ. Fluoxymesterone therapy in treatment of advanced breast cancer. N Engl J Med 1958;259:673-5.
19. Gordan GS., Halden A., Horn Y., Fuery JJ., Parsons RJ., Wlater RM. Calusterone (7Β, 17α-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer. Oncology 1973;28:138-46.
20. McGuire WL., Carbone PP., Sears ME., Escher GC. Estrogen receptors in human breast cancer: an overview. In: McGuire WL., Carbone PP., Vollmer EP., editors. Estrogen receptors in human breast cancer. New York: Raven Press., 1975:1-7.
21. Ingle JN., Twito DI., Schaid DJ., Cullinan SA., Krook JE., Mail-liard JA., Tschetter LK., Long HJ., Gerstner JG., Windschitl HE., Levitt R., Pfeifle DM. Combination hormonal therapy with tamoxifen plus fluoxymesterone vs. tamoxifen alone in post-menopausal women with metastatic breast cancer. A phase II study. Cancer 1991;67:886-91.
22. Tormey DC., Lippman ME., Edwards BK., Cassidy JG. Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer. Ann Intern Med 1983;98:139-44.
23. Gordan GS. Anabolic-androgenic steroids. In: Kochakian CD., editor. Handbook of experimental pharmacology. New York: Springer-Verlag., 1976:499-513.
24. Poulin R., Baker D., Labrie F. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 1988;12:213-25.
25. Dumont M., Dauvois S., Simard J., Garcia T., Schachter B., Labrie F. Antagonism between estrogens and androgens on GC-DFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer. J Steroid Biochem 1989; 34:397-402.
26. Pelletier G., Luu-The V., Têtu B., Labrie F. Immunocytochemical localization of type 5 17Β-hydroxysteroid dehydrogenase in human reproductive tissues. J Histochem Cytochem 1999;47: 731-7.